Elaine O'Hara insider trades
Open-market stock purchases and sales by Elaine O'Hara, EVP, Chief Strategy Officer at Novavax Inc, from SEC Form 4 filings since Mar 1, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 3, 2026 | NVAX Novavax Inc | Sold (not open market) | $213K |
| Mar 3, 2026 | NVAX Novavax Inc | Bought (not open market) | — |
| Mar 2, 2026 | NVAX Novavax Inc | Bought (not open market) | — |
| Mar 2, 2026 | NVAX Novavax Inc | Bought (not open market) | — |
| Mar 2, 2026 | NVAX Novavax Inc | Bought (not open market) | $1.6M |
| Mar 1, 2026 | NVAX Novavax Inc | Sold (not open market) | $54.5K |
| Mar 1, 2026 | NVAX Novavax Inc | Sold (not open market) | $111K |
| Mar 1, 2026 | NVAX Novavax Inc | Bought (not open market) | — |
| Mar 1, 2026 | NVAX Novavax Inc | Bought (not open market) | — |
Companies traded
- NVAX Novavax Inc: other filings, last Mar 3, 2026